1. Home
  2. VEEE vs GNPX Comparison

VEEE vs GNPX Comparison

Compare VEEE & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VEEE
  • GNPX
  • Stock Information
  • Founded
  • VEEE 1994
  • GNPX 2009
  • Country
  • VEEE United States
  • GNPX United States
  • Employees
  • VEEE N/A
  • GNPX N/A
  • Industry
  • VEEE Marine Transportation
  • GNPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VEEE Industrials
  • GNPX Health Care
  • Exchange
  • VEEE Nasdaq
  • GNPX Nasdaq
  • Market Cap
  • VEEE 6.4M
  • GNPX 6.1M
  • IPO Year
  • VEEE 2021
  • GNPX 2018
  • Fundamental
  • Price
  • VEEE $0.29
  • GNPX $0.34
  • Analyst Decision
  • VEEE
  • GNPX Strong Buy
  • Analyst Count
  • VEEE 0
  • GNPX 1
  • Target Price
  • VEEE N/A
  • GNPX $10.00
  • AVG Volume (30 Days)
  • VEEE 53.6K
  • GNPX 9.6M
  • Earning Date
  • VEEE 03-20-2025
  • GNPX 05-13-2025
  • Dividend Yield
  • VEEE N/A
  • GNPX N/A
  • EPS Growth
  • VEEE N/A
  • GNPX N/A
  • EPS
  • VEEE N/A
  • GNPX N/A
  • Revenue
  • VEEE $14,388,517.00
  • GNPX N/A
  • Revenue This Year
  • VEEE N/A
  • GNPX N/A
  • Revenue Next Year
  • VEEE N/A
  • GNPX N/A
  • P/E Ratio
  • VEEE N/A
  • GNPX N/A
  • Revenue Growth
  • VEEE N/A
  • GNPX N/A
  • 52 Week Low
  • VEEE $0.31
  • GNPX $0.22
  • 52 Week High
  • VEEE $0.99
  • GNPX $4.09
  • Technical
  • Relative Strength Index (RSI)
  • VEEE 32.49
  • GNPX 46.59
  • Support Level
  • VEEE $0.32
  • GNPX $0.22
  • Resistance Level
  • VEEE $0.42
  • GNPX $0.44
  • Average True Range (ATR)
  • VEEE 0.03
  • GNPX 0.07
  • MACD
  • VEEE -0.00
  • GNPX 0.01
  • Stochastic Oscillator
  • VEEE 17.85
  • GNPX 36.70

About VEEE Twin Vee PowerCats Co.

Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: